Timely empirical antibiotic therapy against sepsis in a rural Norwegian ambulance service: a prospective cohort study.
Ambulance
Anti-Bacterial Agents
Emergency Medical Services
Emergency Medical Technicians
General practitioners
Paramedics
Primary Care Physicians
Sepsis
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
31 Oct 2024
31 Oct 2024
Historique:
received:
26
09
2024
accepted:
23
10
2024
medline:
31
10
2024
pubmed:
31
10
2024
entrez:
31
10
2024
Statut:
epublish
Résumé
Early diagnosis and antibiotic therapy in patients with sepsis reduce morbidity and mortality, thus pre-hospital management is likely to affect patient outcomes. Pre-hospital administration may increase the risk of unnecessary use of broad-spectrum antibiotics, but identification of an infectious focus enables more targeted antibiotic therapy. The aim of this study was to investigate how paramedics, with or without the assistance of general practitioners, can administer empiric intravenous antibiotic treatment against sepsis in a timely manner. Cohort study of patients with suspected sepsis that received pre-hospital intravenous antibiotics and were transported to hospital. The setting was mainly rural with long average distance to hospital. Patients received targeted antibiotic treatment after an assessment based on clinical work-up supported by scoring systems. Patients were prospectively included from May 2018 to August 2022. Results are presented as median or absolute values, and chi-square tests were used to compare categorical data. We included 328 patients. Median age was 76 years (IQR 64, 83) and 48.5% of patients were female. 30-days all-cause mortality was 10.4%. In cases where a suspected infectious focus was determined, the hospital discharge papers confirmed the pre-hospital diagnosis focus in 195 cases (79.3%). The presence of a general practitioner during the pre-hospital assessment increased the rate of correctly identified infectious focus from 72.6% to 86.1% (p = 0.009). Concordance between pre-hospital identification of a tentative focus and discharge diagnosis was highest for lower respiratory tract (p = 0.02) and urinary tract infections (p = 0.03). Antibiotic treatment was initiated 44 min (median) after arrival of ambulance, and median transportation time to hospital was 69 min. Antibiotic therapy was started 76 min (median) before arrival at hospital. Pre-hospital identification of infectious focus in suspected sepsis was feasible, and collaboration with primary care physicians increased level of diagnostic accuracy. This allowed initiation of intravenous focus-directed antibiotics more than one hour before arrival in hospital in a rural setting. The effect of pre-hospital therapy on timing was much stronger than in previous studies from more urban areas.
Sections du résumé
BACKGROUND
BACKGROUND
Early diagnosis and antibiotic therapy in patients with sepsis reduce morbidity and mortality, thus pre-hospital management is likely to affect patient outcomes. Pre-hospital administration may increase the risk of unnecessary use of broad-spectrum antibiotics, but identification of an infectious focus enables more targeted antibiotic therapy. The aim of this study was to investigate how paramedics, with or without the assistance of general practitioners, can administer empiric intravenous antibiotic treatment against sepsis in a timely manner.
METHODS
METHODS
Cohort study of patients with suspected sepsis that received pre-hospital intravenous antibiotics and were transported to hospital. The setting was mainly rural with long average distance to hospital. Patients received targeted antibiotic treatment after an assessment based on clinical work-up supported by scoring systems. Patients were prospectively included from May 2018 to August 2022. Results are presented as median or absolute values, and chi-square tests were used to compare categorical data.
RESULTS
RESULTS
We included 328 patients. Median age was 76 years (IQR 64, 83) and 48.5% of patients were female. 30-days all-cause mortality was 10.4%. In cases where a suspected infectious focus was determined, the hospital discharge papers confirmed the pre-hospital diagnosis focus in 195 cases (79.3%). The presence of a general practitioner during the pre-hospital assessment increased the rate of correctly identified infectious focus from 72.6% to 86.1% (p = 0.009). Concordance between pre-hospital identification of a tentative focus and discharge diagnosis was highest for lower respiratory tract (p = 0.02) and urinary tract infections (p = 0.03). Antibiotic treatment was initiated 44 min (median) after arrival of ambulance, and median transportation time to hospital was 69 min. Antibiotic therapy was started 76 min (median) before arrival at hospital.
CONCLUSIONS
CONCLUSIONS
Pre-hospital identification of infectious focus in suspected sepsis was feasible, and collaboration with primary care physicians increased level of diagnostic accuracy. This allowed initiation of intravenous focus-directed antibiotics more than one hour before arrival in hospital in a rural setting. The effect of pre-hospital therapy on timing was much stronger than in previous studies from more urban areas.
Identifiants
pubmed: 39478504
doi: 10.1186/s12913-024-11827-x
pii: 10.1186/s12913-024-11827-x
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1320Informations de copyright
© 2024. The Author(s).
Références
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10.
doi: 10.1001/jama.2016.0287
pubmed: 26903338
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–11.
doi: 10.1016/S0140-6736(19)32989-7
pubmed: 31954465
pmcid: 6970225
Skei NV, Nilsen TIL, Knoop ST, Prescott H, Lydersen S, Mohus RM, et al. Long-term temporal trends in incidence rate and case fatality of sepsis and COVID-19-related sepsis in Norwegian hospitals, 2008–2021: a nationwide registry study. BMJ Open. 2023;13(8):e071846.
doi: 10.1136/bmjopen-2023-071846
pubmed: 37532480
pmcid: 10401253
Skei NV, Nilsen TIL, Mohus RM, Prescott HC, Lydersen S, Solligård E, et al. Trends in mortality after a sepsis hospitalization: a nationwide prospective registry study from 2008 to 2021. Infection. 2023;51(6):1773–86.
doi: 10.1007/s15010-023-02082-z
pubmed: 37572240
pmcid: 10665235
Daniels R. Surviving the first hours in sepsis: getting the basics right (an intensivist’s perspective). J Antimicrob Chemother. 2011;66(Suppl 2):ii11-23.
pubmed: 21398303
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.
doi: 10.1097/01.CCM.0000217961.75225.E9
pubmed: 16625125
Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–55.
doi: 10.1097/CCM.0000000000000330
pubmed: 24717459
Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. N Engl J Med. 2017;376(23):2235–44.
doi: 10.1056/NEJMoa1703058
pubmed: 28528569
pmcid: 5538258
Lockey D. International EMS systems: Geographical lottery and diversity but many common challenges. Resuscitation. 2009;80(7):722.
doi: 10.1016/j.resuscitation.2009.04.006
pubmed: 19427091
Alam N, Oskam E, Stassen PM, Exter PV, van de Ven PM, Haak HR, et al. Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 2018;6(1):40–50.
doi: 10.1016/S2213-2600(17)30469-1
pubmed: 29196046
Jones J, Allen S, Davies J, Driscoll T, Ellis G, Fegan G, et al. Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe). Sci Rep. 2021;11(1):18586.
doi: 10.1038/s41598-021-97979-w
pubmed: 34545117
pmcid: 8452688
Walchok JG, Pirrallo RG, Furmanek D, Lutz M, Shope C, Giles B, et al. Paramedic-initiated CMS sepsis core measure bundle prior to hospital arrival: a stepwise approach. Prehosp Emerg Care. 2017;21(3):291–300.
doi: 10.1080/10903127.2016.1254694
pubmed: 27918869
Cunningham CT, Sanseverino A, Reznek M, Borges E, Beth Urhoy M, Gross K, et al. A pilot study of prehospital antibiotics for severe sepsis. Acad Emerg Med. 2022;29(2):231–3.
doi: 10.1111/acem.14388
pubmed: 34480817
Statistics Norway: https://www.ssb.no Accessed 2024–06–20
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45(3):486–552.
doi: 10.1097/CCM.0000000000002255
pubmed: 28098591
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–247.
doi: 10.1007/s00134-021-06506-y
pubmed: 34599691
pmcid: 8486643
Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2023;13(1):55–161.
doi: 10.1093/ehjacc/zuad107
Seymour CW, Kahn JM, Martin-Gill C, Callaway CW, Yealy DM, Scales D, Angus DC. Delays From First Medical Contact to Antibiotic Administration for Sepsis. Crit Care Med. 2017;45(5):759–65.
doi: 10.1097/CCM.0000000000002264
pubmed: 28234754
pmcid: 6065262
The Norwegian Directorate of Health https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-primaerhelsetjenesten (In Norwegian) Accessed 2024–06–20
The Norwegian Directorate of Health https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-sykehus (In Norwegian) Accessed 2024–06–20
NORM/NORM-VET 2022. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø / Oslo 2023. ISSN:1502–2307 (print) / 1890–9965 (electronic) Available at http://www.antibiotikaresistens.no .